Security key
370920100
Generate Biomedicines, Inc. - Common Stock, $0.001 par value per share (GENB)
CUSIP: 370920100
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 15,600
- Total 13F value
- $263,172
- Share change
- -5,762
- SEC-reported price per share
- $16.87
- Number of holders
- 1
- Value change
- -$3,353
- Number of buys
- 1
- Number of sells
- 2
- Shares outstanding
- 128,224,775
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
GENB full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Generate Biomedicines, Inc. SEC filings
Generate Biomedicines, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 370920100
Recent filing periods:
Ownership snapshot
Top reported holders of GENB - Generate Biomedicines, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Flagship Pioneering, LLC
Disclosed value leader
Flagship Pioneering, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 49%
13D/G row: Flagship Pioneering, LLC
Showing 1-6 of 15 holder rows.
Quick read
Flagship Pioneering, LLC leads the comparable SEC ownership view at 49%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Flagship Pioneering, LLC's linked filing trail.
Comparable ownership
Top 5
Flagship Pioneering, LLC
49%
Michael Nally
5.2%
FMR LLC
3.3%
Capital World Investors
3.1%
BRAIDWELL LP
2.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Flagship Pioneering, LLC |
13D/G
13F
Afeyan Noubar · Company
|
49%
|
$802,584,512
62,701,915 shares
|
$0 | 31 Mar 2026 |
| Michael Nally |
13D/G
3/4/5
Nally Michael · Chief Executive Officer, Director
|
5.2%
|
$88,563,853
6,919,051 shares
|
$0 | 31 Mar 2026 |
| FMR LLC |
13F
Company
|
3.3%
|
$52,719,051
4,217,524 shares
|
— | 31 Mar 2026 |
| Capital World Investors |
13F
Company
|
3.1%
|
$50,051,863
4,004,149 shares
|
— | 31 Mar 2026 |
| BRAIDWELL LP |
13F
Company
|
2.8%
|
$44,912,488
3,592,999 shares
|
— | 31 Mar 2026 |
| JPMORGAN CHASE & CO |
13F
Company
|
2.3%
|
$33,922,951
2,947,259 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
15,600
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
57
Q2 2026 holders
1
Holder diff
-56
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend